Clairo

Director, Cardiac Sales

United Kingdom

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Life Sciences, Medical Devices, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree and 5+ years of sales experience, with a proven ability to execute a sales strategy directly and through a professional sales force. Knowledgeable in clinical research and diagnostics, and experience in both large and small company environments is required, along with a demonstrated record of success in major account and consultative sales, and experience managing and penetrating large, multinational accounts in the life sciences arena.

Responsibilities

The Director, Cardiac Sales will develop and execute the Cardiac line’s executive strategy, sales objectives, and bookings goals, as well as develop and execute programs to drive new sales. They will work closely with the CS Product Management team to support the development of new offerings, participate in sales and product management meetings, coordinate with Clario Business Development personnel, negotiate and contract new business, lead strategic meetings, and provide on-going product training for Business Development. The role also includes day-to-day management & tracking of assigned product line’s sales activities, collaborating with Clario sales and product management to ensure alignment, and fulfilling administrative responsibilities such as time management and travel expenses.

Skills

Sales Leadership
Strategic Planning
Clinical Research
Diagnostics
Account Management
Consultative Sales
Multinational Account Penetration

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI